Prof. Prabir Patra, Jerome A Gilbert Endowed Chair Professor and Founding Department Chair of Biomedical Engineering at Marshall University, recently participated in the prestigious 2024 Biomedical Engineering Society (BMES) Annual Meeting, held from October 23-26, 2024, in Baltimore, MD, USA. During this event, Prof. Patra actively promoted our journal EM, to a global audience of biomedical engineers and researchers.

At the booth, Prof. Patra showcased EM's latest achievements through informative flyers. In addition to the visual display, Prof. Patra engaged in meaningful conversations with several visitors, discussing the journal's impact, scope, and the benefits of publishing with EM. His presence at the event not only highlighted the journal's reputation but also fostered potential collaborations and submissions from the meeting's participants.

EM aims to broaden our reach and enhance the visibility of our scholarly publications. We actively endorse our Editorial Board and Guest Editors in the identification of high-caliber conferences for journal promotion. Proactively pursuing further collaborative and sponsorship opportunities, we are dedicated to amplifying the reach of our journal and ensuring the widespread distribution of our content, all while maintaining free access to our research findings. This approach underscores our dedication to advancing the exchange of knowledge within the global scientific community.

To learn more about EM and its contributions to the field of medicine, please visit https://www.explorationpub.com/Journals/em. For more information about the 2024 BMES Annual Meeting, please visit their official website at https://www.bmes.org/bmes2024.

The EM journal took great pride in sponsoring the 30th Congress of the International Society of Hypertension - ISH 2024 (https://ish2024.org/). This esteemed event, held from September 19-22, 2024, in the vibrant city of Cartagena, Colombia, attracted over 1200 hypertension experts and enthusiasts from across the globe.

As a dedicated sponsor, we strategically prepared 2000 flyers that were personally included in the congress bags of each attendee, offering a direct introduction to EM journal. Additionally, our journal enjoyed prominent visibility on the ISH 2024 website, including a special mention on the Confirmed Sponsors page, which greatly broadened our reach: https://ish2024.org/confirmed-sponsors/.

The ISH 2024 not only served as a congress but also as a catalyst for EM to engage with the hypertension specialists worldwide, enhancing our journal's visibility and fostering meaningful connections with medical professionals.

At EM, we are committed to expanding our horizons. We encourage our Editorial Board and Guest Editors to identify and recommend prestigious conferences. We will actively seek additional opportunities for cooperation and sponsorship, demonstrating our commitment to not only promoting our journal but also to disseminating our content freely and widely.

Over the past year, Exploration of Medicine has achieved an increasing impact and larger number of citations. We truly appreciate all of your wonderful support! At the beginning of 2024, we are delighted to announce and recognize the winners of “Highly Cited Paper Award 2023” to express our gratitude to those authors.

Criteria for Selection and Award:

● All articles published in 2022-2023;

● Both regular and special issue submissions are considered;

● Citations are counted according to Web of Science (WOS) in 2023;

● Prize for the author team: 300-1,000 USD, certificate of “Highly Cited Paper Award”;

● Prize for the corresponding Guest Editor(s): 100-300 USD.

Winning Papers:

● Hyperuricemia-a serious complication among patients with chronic kidney disease: a systematic review and meta-analysis

Authors: Ishfaq Rashid, Pooja Katravath, Pramil Tiwari, Sanjay D’Cruz, Shivani Jaswal, Gautam Sahu

Belongs to the Special Issue: Disease Diagnosis, Molecular Mechanism and Therapeutic Strategies in Kidney Injury and Fibrosis

● Reactive oxygen species in cancer progression and its role in therapeutics

Authors: Ranjeet Singh, Partha Pratim Manna

Belongs to the Special Issue: Reactive Oxygen Species (ROS) in Pathophysiological Conditions

Congratulations! We believe these articles will be more shining in the future.

In the following year, we will continue to set “Highly Cited Paper Award” to recognize the relevant authors. On behalf of the Editorial Board and Editorial Office, we welcome more outstanding researchers to participate in and contribute to our journal. Our journal is always open to you!

In an important stride towards global recognition, our Associate Editor, Prof. Hua Su participated in the International Stroke Conference (ISC) 2024 and effectively promoted the EM journal here. The conference is the world's premier meeting in stroke, cerebrovascular disease, and brain health, which was held in Phoenix (February 7-9) this year.

Armed with a concise yet informative flyer, Prof. Su engaged with her peers and interested attendees. The response to our journal's promotion was positive and enthusiastic (see the picture). Prof. Su's participation was a strategic move to not only learn from the best in the field but also to enhance EM's visibility and impact.

During November 1-5, our Editor-in-Chief Prof. Lindsay Farrer attended the ASHG 2023 Annual Meeting (American Society of Human Genetics) in Washington, DC, USA, and promoted our journal in this biggest convene of human genetics and genomics research, more than 8,000 attendees around the world this year. With the greatest help of Prof. Farrer, we were so excited to introduce EM and meet the immense community of genetic researchers, clinicians, and educators on-site. See our flyer for ASHG.

And EM is looking forward to more promotion and collaboration with excellent researchers, associations, and conferences. Join us to do this. You will be fully supported and your effort here will be awarded.

Over the past year, Exploration of Medicine has achieved an increasing impact and larger number of citations. We sincerely thank everyone’s great support! At the beginning of 2023, we are thrilled to announce and recognize the winners of “Highly Cited Paper Award 2022” to show our appreciation to those authors.

Criteria for Selection and Award:

● Original Articles and Reviews published in 2020-2022;

● Both regular and special issue submissions are considered;

● Citations are counted according to Web of Science (WOS) in 2022;

● Prize for the author team: 300-1,000 USD, certificate of “Highly Cited Paper Award”;

● Prize for the corresponding Guest Editor(s): 100-300 USD.

Winning Papers:

● PNPLA3 gene and kidney disease

Alessandro Mantovani, Chiara Zusi

● Nonalcoholic fatty liver disease and type 2 diabetes: pathophysiological mechanisms shared between the two faces of the same coin

Carlo Acierno, Alfredo Caturano, Pia Clara Pafundi, Riccardo Nevola, Luigi Elio Adinolfi, Ferdinando Carlo Sasso

Special Issue: Exploring NAFLD/NASH

● Sex differences in non-alcoholic fatty liver disease: hints for future management of the disease

Noel C. Salvoza, Pablo J. Giraudi, Claudio Tiribelli, Natalia Rosso

Special Issue: Exploring NAFLD/NASH

Congratulations! We believe these articles will be more shining in the future.

In the following year, we will continue to set “Highly Cited Paper Award” to recognize the related authors. On behalf of the Editorial Board and Editorial Office, we warmly welcome more outstanding researchers to participate in and contribute to the journal. Our thriving journal is always open to you!

Since July 2022, three talented researchers have joined the Editorial Board of EM. They are (from left to right):

Prof. Fabio Monzani, PhD (43 of H-Index) from University of Pisa, Italy

Prof. Tamas Fulop, MD, PhD (66 of H-Index) from University of Sherbrooke, Canada

Prof. Simona G. Bungau, PhD (33 of H-Index) from University of Oradea, Romania

Prof. Fabio Monzani and Prof. Tamas Fulop are distinguished experts in the field of geriatrics. Prof. Simona G. Bungau achieved significant work in the fields of pharmacology and public health. It is our great honor to have them in EM, and we hope they will enjoy this new role and have a rewarding experience in EM. For more information about the EM Editorial Board: https://www.explorationpub.com/Journals/em/Editorial_Board.

Since April 2022, eight talented researchers have joined the Editorial Board of EM. They are:

Prof. Chao Wang (75 of H-Index) from Soochow University, China;

Prof. Luis Gabriel Navar (79 of H-Index) from Tulane University School of Medicine, USA;

Prof. Esma R. Isenovic (29 of H-Index) from University of Belgrade, Serbia;

Dr. Zeneng Wang (54 of H-Index) from Lerner Research Institute, USA; 

Prof. Peng Mi (30 of H-Index) from West China Hospital of Sichuan University, China;

Prof. Guangwen Cao (47 of H-Index) from Naval Medical University, China;

Prof. Jannis Kountouras (52 of H-Index) from Aristotle University of Thessaloniki, Greece;

Prof. Jun Ren (80 of H-Index) from Fudan University, China.

These scholars are all highly accomplished and prominent in their respective research fields. It is our great honor to have them in EM, and we hope they will enjoy their new meaningful role in this promising journal. For more information about the EM Editorial Board: https://www.explorationpub.com/Journals/em/Editorial_Board

We are so proud to announce that Exploration of Medicine has been COPE (Committee on Publication Ethics) Member. EM has achieved this recognition as a journal committed to the highest standards in publication ethics. Please feel free to check the profile of EM at COPE now: https://publicationethics.org/members/exploration-medicine.

We are thrilled and honored to share this significant breakthrough with all of you: Our application for Scopus has been accepted. Within one month, EM journal will be listed in the Scopus Title list. We thank all our editorial board, authors, reviewers, editorial staff, readers, as you have made tremendous effort and contribution to this rapid milestone and fast development of this journal in just two years since EM launched.

Very cheerfully we cannot wait to share with you the big news: on March 14, EM’s application for COPE (Committee on Publication Ethics) membership was approved! That shows EM's reputation of following the highest standards of publication ethics. And Exploration of Medicine will be in the COPE Member official list in 1-2 weeks.

With great honor and deepest gratitude, Exploration of Medicine has awarded the "Highly Cited Paper Award" in 2020–2021. These inspiring and impactful papers have been enhancing the name and influence of EM since publication. And the authors are heartily recognized for bringing their best contributions.

Notes for the Award

– Original research articles and reviews published in 2020 and 2021;

– Both regular and Special Issue submissions are considered;

– Citations are counted according to Web of Science (WOS) in 2020 and 2021.

After careful evaluation based on quality, citations in WOS, and downloads, six articles have been selected, and the author teams will be awarded $1000, $600 and $300 respectively. The authors will also receive a "Highly Cited Paper Award" certificate issued by the journal. In addition, the corresponding Guest Editor will also be awarded $300, $200 and $100 respectively.

First Prize

Perspectives of nonalcoholic fatty liver disease research: a personal point of view

Amedeo Lonardo, Stefano Ballestri

Special Issue: Exploring NAFLD/NASH

Second Prize

Nonalcoholic fatty liver disease and portal hypertension

Marvin Ryou, Nicholas Stylopoulos, Gyorgy Baffy

Special Issue: Exploring NAFLD/NASH

Nonalcoholic fatty liver disease and type 2 diabetes: pathophysiological mechanisms shared between the two faces of the same coin

Carlo Acierno, Alfredo Caturano, Pia Clara Pafundi, Riccardo Nevola, Luigi Elio Adinolfi, Ferdinando Carlo Sasso

Special Issue: Exploring NAFLD/NASH

Third Prize

Sex differences in non-alcoholic fatty liver disease: hints for future management of the disease

Noel C. Salvoza, Pablo J. Giraudi, Claudio Tiribelli, Natalia Rosso

Special Issue: Exploring NAFLD/NASH

Current evidence and outcomes for retinopathy of prematurity prevention: insight into novel maternal and placental contributions

Lara Carroll, Leah A. Owen

Using machine intelligence to uncover Alzheimer's disease progression heterogeneity

Bessi Qorri, Mike Tsay, Abhishek Agrawal, Rhoda Au, Joseph Geraci

Special Issue: Digital Biomarkers: The New Frontier for Medicine and Research

Congratulations to these authors! On behalf of the Editorial Board and Editorial Office, we sincerely appreciate the great support they provided to this rising journal at its early stage. In 2022 we will continue to set the Highly Cited Paper Award to recognize authors who contribute high-quality publications to the journal.

We were honored and pleased to announce our publisher Open Exploration Publishing was recognized as membership of OASPA (Open Access Scholarly Publishing Association). And we believe EM journal will also win a growing name and recognition as our publisher joined this major scholarly organization. https://oaspa.org/member/open-exploration-publishing-inc/

We were honored to be included in CAS and BASE databases. Both are voluminous content providers. Being indexed in CAS and BASE means that EM will receive an increased audience for our articles.

Find more about CAS and BASE: https://www.cas.org/; https://www.base-search.net/.

We are pleased to announce that Exploration of Medicine is now indexed in the Directory of Open Access Journals (DOAJ), an online directory that indexes and provides access to quality open access, peer-reviewed journals. Check the journal on DOAJ website at https://www.doaj.org/toc/2692-3106. Launched in 2020, this fully Open Access journal continues to grow in scope and influence.

Open Exploration, publisher of EM, joined the Initiative for Open Abstracts (I4OA) to support the “unrestricted availability of the abstracts of the world's scholarly publications in trusted repositories where they are open and machine-accessible” (from https://i4oa.org/). Read more about it, https://www.explorationpub.com/oep/index/17.

With great honor and pleasure, we announced that Dr. George J. Murphy joined our editorial board as the Associate Editor for the section “Regenerative Medicine”. Dr. Murphy is Associate Professor of Medicine in the Division of Hematology and Oncology at Boston University School of Medicine. In addition, he is Co-Director of the Boston University Center for Regenerative Medicine. Meet more talented editorial board of EM here.

Join us to welcome our new Associate Editors Dr. Shannon L. Risacher (left, "Radiology, Nuclear Medicine & Imaging" section) and Dr. Lee M. Wetzler (right, "Microbiology, Immunology & Infectious Disease" section). Dr. Risacher is Assistant Professor of Radiology & Imaging Sciences at Indiana University School of Medicine. Dr. Wetzler is Professor of Medicine and Microbiology at Boston University School of Medicine. With their great expertise, we believe they will bring in a particular and wider perspective to the section and journal. Learn more about EM editorial board, https://www.explorationpub.com/Journals/em/Editorial_Board.

Exploration of Medicine is recognized in the list of "Journals stating that they follow the ICMJE Recommendations" (http://www.icmje.org/journals-following-the-icmje-recommendations/). From the first day of EM, we adhere to the ICMJE Recommendations to ensure the rigorousness of review and publication process.